A consumer advocacy group is calling on federal regulators to crack down on businesses that claim laser acupuncture can help smokers kick the habit. Alex Cohen reports.
If there was ever a good time to have high cholesterol, this might be it. The patent on the cholesterol-lowering statin drug, Zocor, expires today. So, generics will soon hit the market, bringing prices down. Helen Palmer reports.
No surprise that the cost of brand-name prescription drugs is on the rise, but a new study reveals the cost has skyrocketed this year — three times faster than the rate of inflation. Stacey Vanek-Smith reports.
Today Merck's blockbuster cholesterol-lowering drug Zocor loses its patent. Usually when a brand drug goes generic, the price drops sharply. But Merck's not giving up market share without a fight. Helen Palmer reports.
Nurses in four cities have filed lawsuits naming two big hospital chains, saying their employers illegally shared wage information. They're demanding millions in back pay and other compensation. Janet Babin reports.
Researchers report that a drug commonly used to treat heart disease might also help lessen the debilitating effects of stroke. But getting it to market as a stroke drug might be difficult. Helen Palmer reports.
Swiss food giant Nestle today said it's going to fatten up its nutritional portfolio, paying $600 million for diet company Jenny Craig. Lisa Napoli reports.
Now that Bill Gates is devoting himself to philanthropic efforts, could he become the next John D. Rockefeller? Helen Palmer reports on what his changed role could mean to health care.
The AMA has changed the criteria for juvenile obesity, expanding the number of children deemed overweight. A report out today says the move largely benefits drug companies and humiliates kids. Janet Babin explains.
